Viking Therapeutics (VKTX) Cash from Operations (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly Cash from Operations came in at -$125.2 million in Q2 2026, down 165.98% year-over-year from $189.7 million in Q2 2025, and down 9.82% quarter-over-quarter from -$114.0 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Cash from Operations (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Cash from Operations across 13 years of filings, most recently posting -$125.2 million for Q2 2026.
- In Q2 2026, Cash from Operations fell 165.98% year-over-year to -$125.2 million; the TTM figure through Jun 2026 stood at -$418.4 million (down 174.32% YoY), while the FY2025 annual figure was -$278.7 million, down 217.45% from the prior year.
- Cash from Operations came in at -$125.2 million for Q2 2026 at Viking Therapeutics, down from -$114.0 million in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of -$6.1 million in Q1 2024 to a low of -$125.2 million in Q2 2026.
- Average Cash from Operations over 5 years is -$40.4 million, with a median of -$23.3 million recorded in 2023.
- Year-over-year, Cash from Operations jumped 75.11% in 2024 and tumbled 753.13% in 2025.
- Over 5 years, Cash from Operations stood at -$10.9 million in 2022, then tumbled by 61.45% to -$17.6 million in 2023, then plunged by 76.76% to -$31.2 million in 2024, then slumped by 173.53% to -$85.3 million in 2025, then tumbled by 46.76% to -$125.2 million in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were -$125.2 million in Q2 2026, -$114.0 million in Q1 2026, and -$85.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 2.87 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | -125.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -125.17 Mn |
| Mar 31, 2026 | -113.98 Mn |
| Dec 31, 2025 | -85.29 Mn |
| Sep 30, 2025 | -94.00 Mn |
| Jun 30, 2025 | -47.06 Mn |
| Mar 31, 2025 | -52.33 Mn |
| Dec 31, 2024 | -31.18 Mn |
| Sep 30, 2024 | -21.96 Mn |
| Jun 30, 2024 | -28.51 Mn |
| Mar 31, 2024 | -6.13 Mn |
| Dec 31, 2023 | -17.64 Mn |
| Sep 30, 2023 | -19.66 Mn |
| Jun 30, 2023 | -11.44 Mn |
| Mar 31, 2023 | -24.64 Mn |
| Dec 31, 2022 | -10.93 Mn |
| Sep 30, 2022 | -13.50 Mn |
| Jun 30, 2022 | -13.44 Mn |
| Mar 31, 2022 | -10.53 Mn |
| Dec 31, 2021 | -12.35 Mn |
| Sep 30, 2021 | -10.93 Mn |
API Access
Viking Therapeutics Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();